These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38834643)

  • 21. Structure of cyclic peptides: the crystal and solution conformation of cyclo(Phe-Phe-Aib-Leu-Pro).
    Zanotti G; Saviano M; Saviano G; Tancredi T; Rossi F; Pedone C; Benedetti E
    J Pept Res; 1998 Jun; 51(6):460-6. PubMed ID: 9650721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solid state structural analysis of the cyclooctapeptide cyclo- (Pro1-Pro-Phe-Phe-Ac6c-Ile-D-Ala-Val8).
    Saviano M; Isernia C; Rossi F; Di Blasio B; Iacovino R; Mazzeo M; Pedone C; Benedetti E
    Biopolymers; 2000 Feb; 53(2):189-99. PubMed ID: 10679623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Probing the bioactive conformation of an archetypal natural product HDAC inhibitor with conformationally homogeneous triazole-modified cyclic tetrapeptides.
    Horne WS; Olsen CA; Beierle JM; Montero A; Ghadiri MR
    Angew Chem Int Ed Engl; 2009; 48(26):4718-24. PubMed ID: 19267380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conformations and conformational interconversions of diastereomeric cyclic tetraprolines.
    Link U; Mästle W; Rothe M
    Int J Pept Protein Res; 1993 Nov; 42(5):475-83. PubMed ID: 8106200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of the Microbial Cyclic Tetrapeptide Trapoxin A to the Class I Histone Deacetylase HDAC8.
    Porter NJ; Christianson DW
    ACS Chem Biol; 2017 Sep; 12(9):2281-2286. PubMed ID: 28846375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structures of a D-residue containing tetrapeptides. 1. tert-Boc-D-valyl-alanyl-leucyl-alanyl-methoxide, butanol solvate.
    Bobde V; Durani S; Pattabhi V; Sadasivan C
    Int J Pept Protein Res; 1995 Apr; 45(4):332-6. PubMed ID: 7601606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conformation and dynamics of a cyclic disulfide-bridged peptide: effects of temperature and solvent.
    Li F; Bravo-Rodriguez K; Phillips C; Seidel RW; Wieberneit F; Stoll R; Doltsinis NL; Sanchez-Garcia E; Sander W
    J Phys Chem B; 2013 Apr; 117(13):3560-70. PubMed ID: 23514118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and solution structure of an S-glycosylated cyclic hexapeptide. Evidence for conformational change induced by glycosylation.
    Gerz M; Matter H; Kessler H
    Int J Pept Protein Res; 1994 Mar; 43(3):248-57. PubMed ID: 8005747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular design of histone deacetylase inhibitors by aromatic ring shifting in chlamydocin framework.
    Shivashimpi GM; Amagai S; Kato T; Nishino N; Maeda S; Nishino TG; Yoshida M
    Bioorg Med Chem; 2007 Dec; 15(24):7830-9. PubMed ID: 17881232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preferential heterochiral cyclic trimerization of 5-(aminoethyl)-2-furancarboxylic acid (AEFC) driven by non-covalent interactions.
    Suresh Kumar NV; Singh H; Pulukuri KK; Chakraborty TK
    J Mol Graph Model; 2012 Sep; 38():13-25. PubMed ID: 23079639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta2-amino acids in the design of conformationally homogeneous cyclo-peptide scaffolds.
    Norgren AS; Büttner F; Prabpai S; Kongsaeree P; Arvidsson PI
    J Org Chem; 2006 Sep; 71(18):6814-21. PubMed ID: 16930031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, evaluation and molecular modeling of cyclic tetrapeptide histone deacetylase inhibitors as anticancer agents.
    Huang D; Li X; Sun L; Xiu Z; Nishino N
    J Pept Sci; 2012 Apr; 18(4):242-51. PubMed ID: 22253009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure, histone deacetylase, and antiprotozoal activities of apicidins B and C, congeners of apicidin with proline and valine substitutions.
    Singh SB; Zink DL; Liesch JM; Dombrowski AW; Darkin-Rattray SJ; Schmatz DM; Goetz MA
    Org Lett; 2001 Sep; 3(18):2815-8. PubMed ID: 11529764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformational change of ascidiacyclamide caused by asymmetric modification for an isoleucine residue: structural analyses of [Gly], [Leu], and [Phe]ascidiacyclamides by x-ray diffraction and NMR spectroscopy.
    Doi M; Shinozaki F; In Y; Ishida T; Yamamoto D; Kamigauchi M; Sugiura M; Hamada Y; Kohda K; Shioiri T
    Biopolymers; 1999 May; 49(6):459-69. PubMed ID: 10193193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, conformational studies, and molecular dynamics calculations of two cyclic tetrapeptides with 17- and 18-membered rings.
    Hölzemann G; Pachler KG; Eberhart B; Hölzel H; Kraft M; Barnickel G
    Int J Pept Protein Res; 1991 Apr; 37(4):283-92. PubMed ID: 1894444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conformational investigation of alpha,beta-dehydropeptides. Part. IV. Beta-turn in saturated and alpha,beta-unsaturated peptides Ac-Pro-Xaa-NHCH3: NMR and IR studies.
    Pietrzyński G; Rzeszotarska B; Kubica Z
    Int J Pept Protein Res; 1992 Dec; 40(6):524-31. PubMed ID: 1286936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacicyclin, a new antibacterial cyclic hexapeptide from Bacillus sp. strain BC028 isolated from Mytilus edulis.
    Wiese J; Abdelmohsen UR; Motiei A; Humeida UH; Imhoff JF
    Bioorg Med Chem Lett; 2018 Feb; 28(4):558-561. PubMed ID: 29422389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling of peptides containing D-amino acids: implications on cyclization.
    Yongye AB; Li Y; Giulianotti MA; Yu Y; Houghten RA; Martínez-Mayorga K
    J Comput Aided Mol Des; 2009 Sep; 23(9):677-89. PubMed ID: 19593648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of all-L cyclic tetrapeptides using pseudoprolines as removable turn inducers.
    Fairweather KA; Sayyadi N; Luck IJ; Clegg JK; Jolliffe KA
    Org Lett; 2010 Jul; 12(14):3136-9. PubMed ID: 20565133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The first biologically active synthetic analogues of FK228, the depsipeptide histone deacetylase inhibitor.
    Yurek-George A; Cecil AR; Mo AH; Wen S; Rogers H; Habens F; Maeda S; Yoshida M; Packham G; Ganesan A
    J Med Chem; 2007 Nov; 50(23):5720-6. PubMed ID: 17958342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.